<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04590703</url>
  </required_header>
  <id_info>
    <org_study_id>ALLO-ASC-DFU-303</org_study_id>
    <nct_id>NCT04590703</nct_id>
  </id_info>
  <brief_title>A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial</brief_title>
  <official_title>A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 3 Clinical Trial of ALLO-ASC-DFU-301</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anterogen Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anterogen Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a follow-up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment&#xD;
      in phase 3 clinical trial (ALLO-ASC-DFU-301) for 24 months&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open-label follow up study to evaluate the safety for the subjects with&#xD;
      ALLO-ASC-DFU treatment in phase 3 clinical trial (ALLO-ASC-DFU-301) for 24 months.&#xD;
      ALLO-ASC-DFU is a hydrogel sheet containing allogenic adipose-derived mesenchymal stem cells.&#xD;
      Adipose-derived stem cells have anti-inflammatory effect and release growth factors such as&#xD;
      vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), which can&#xD;
      enhance wound healing and regeneration of new tissue, finally may provide a new option in&#xD;
      treating a Diabetic Foot Ulcer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of systemic tolerance through incidence of abnormal laboratory test results</measure>
    <time_frame>Up to 9 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of incidence of clinically significant change in physical examination and vital signs</measure>
    <time_frame>Up to 18 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of localized tolerance through incidence of clinically significant change about treatment area</measure>
    <time_frame>Up to 24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of incidence of adverse events</measure>
    <time_frame>Up to 24 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Diabetic Foot Ulcer</condition>
  <arm_group>
    <arm_group_label>ALLO-ASC-DFU</arm_group_label>
    <description>Subjects with ALLO-ASC-DFU treatment in phase 3 clinical trial of ALLO-ASC-DFU-301</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vehicle sheet</arm_group_label>
    <description>Subjects with Vehicle sheet treatment in phase 3 clinical trial of ALLO-ASC-DFU-301</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ALLO-ASC-DFU</intervention_name>
    <description>Application of ALLO-ASC-DFU sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.</description>
    <arm_group_label>ALLO-ASC-DFU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vehicle sheet</intervention_name>
    <description>Application of Vehicle sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.</description>
    <arm_group_label>Vehicle sheet</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who are treated with ALLO-ASC-DFU sheet or Vehicle sheet in phase 3 clinical trial&#xD;
        of ALLO-ASC-DFU-301.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects who are treated with ALLO-ASC-DFU sheet or Vehicle sheet in phase 3 clinical&#xD;
             trial of ALLO-ASC-DFU-301.&#xD;
&#xD;
          2. Subjects who are able to give written informed consent prior to study start and to&#xD;
             comply with the study requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        1. Subjects who are considered not suitable for the study by the principal investigator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SeungKyu Han, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>KiWon Young, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nowon Eulji Medical Center, Eulji University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>JunPyo Hong, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>JunHyeong Kim, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung University Dongsan Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chan Kang, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungnam National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>HyungMin Hahn, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ChanYeong Heo, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>YoungKoo Lee, MD. Ph D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung-Kyu Han, MD. Ph D.</last_name>
    <phone>+82-02-2626-3333</phone>
    <email>pshan@kmuc.or.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <state>Chungcheongnam-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan Kang, MD. Ph D.</last_name>
      <phone>+82-042-338-2419</phone>
      <email>faschan@daum.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi-do</state>
        <zip>14584</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>YoungKoo Lee, MD. Ph D.</last_name>
      <phone>+82-032-621-6705</phone>
      <email>brain0808@hanmail.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ChanYeong Heo, MD. Ph D.</last_name>
      <email>lionheo@sun.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ajou University Medical Center</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggi-do</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HyungMin Hahn, MD. Ph D.</last_name>
      <phone>+82-031-219-5239</phone>
      <email>i00325@aumc.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <state>Gyeongsangnam-do</state>
        <zip>42601</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JunHyeong Kim, MD. Ph D.</last_name>
      <phone>+82-053-250-7637</phone>
      <email>med69@dsmc.or.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nowon Eulji Medical Center, Eulji University</name>
      <address>
        <city>Seoul</city>
        <zip>01830</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kiwon Yang, MD. Ph D.</last_name>
      <phone>+82-02-970-8259</phone>
      <email>youngkw1@hanmail.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JunPyo Hong, MD. Ph D.</last_name>
      <phone>+82-02-3010-3606</phone>
      <email>joonphong@amc.seoul.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SeungKyu Han, MD. Ph D.</last_name>
      <phone>+82-02-2626-3333</phone>
      <email>pshan@kmuc.or.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 9, 2020</last_update_submitted>
  <last_update_submitted_qc>October 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

